Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline.

Santomasso BD, Nastoupil LJ, Adkins S, Lacchetti C, Schneider BJ, Anadkat M, Atkins MB, Brassil KJ, Caterino JM, Chau I, Davies MJ, Ernstoff MS, Fecher L, Funchain P, Jaiyesimi I, Mammen JS, Naidoo J, Naing A, Phillips T, Porter LD, Reichner CA, Seigel C, Song JM, Spira A, Suarez-Almazor M, Swami U, Thompson JA, Vikas P, Wang Y, Weber JS, Bollin K, Ghosh M

Open source

DOI: 10.1200/jco.21.01992
Published: 2021 Dec 10
Container: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco.21.01992,
  title = {Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline.},
  author = {Santomasso BD and Nastoupil LJ and Adkins S and Lacchetti C and Schneider BJ and Anadkat M and Atkins MB and Brassil KJ and Caterino JM and Chau I and Davies MJ and Ernstoff MS and Fecher L and Funchain P and Jaiyesimi I and Mammen JS and Naidoo J and Naing A and Phillips T and Porter LD and Reichner CA and Seigel C and Song JM and Spira A and Suarez-Almazor M and Swami U and Thompson JA and Vikas P and Wang Y and Weber JS and Bollin K and Ghosh M},
  year = {2021},
  journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  doi = {10.1200/jco.21.01992},
  url = {https://doi.org/10.1200/jco.21.01992}
}

RIS

TY  - JOUR
TI  - Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline.
AU  - Santomasso BD
AU  - Nastoupil LJ
AU  - Adkins S
AU  - Lacchetti C
AU  - Schneider BJ
AU  - Anadkat M
AU  - Atkins MB
AU  - Brassil KJ
AU  - Caterino JM
AU  - Chau I
AU  - Davies MJ
AU  - Ernstoff MS
AU  - Fecher L
AU  - Funchain P
AU  - Jaiyesimi I
AU  - Mammen JS
AU  - Naidoo J
AU  - Naing A
AU  - Phillips T
AU  - Porter LD
AU  - Reichner CA
AU  - Seigel C
AU  - Song JM
AU  - Spira A
AU  - Suarez-Almazor M
AU  - Swami U
AU  - Thompson JA
AU  - Vikas P
AU  - Wang Y
AU  - Weber JS
AU  - Bollin K
AU  - Ghosh M
PY  - 2021
JO  - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
DO  - 10.1200/jco.21.01992
UR  - https://doi.org/10.1200/jco.21.01992
ER  -

APA

BD, S., LJ, N., S, A., C, L., BJ, S., M, A., MB, A., KJ, B., JM, C., I, C., MJ, D., MS, E., L, F., P, F., I, J., JS, M., J, N., A, N., T, P., LD, P., CA, R., C, S., JM, S., A, S., M, S., U, S., JA, T., P, V., Y, W., JS, W., K, B., & M, G. (2021). Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco.21.01992

Source records

pubmed · retrieved 2026-09-25T19:44:42.234Z